Liensinine Perchlorate

CAS No. 2385-63-9

Liensinine Perchlorate( —— )

Catalog No. M18286 CAS No. 2385-63-9

Liensinine is the active constituent of plumula nelambinis with anti-hypertension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 In Stock
10MG 90 In Stock
25MG 163 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liensinine Perchlorate
  • Note
    Research use only, not for human use.
  • Brief Description
    Liensinine is the active constituent of plumula nelambinis with anti-hypertension.
  • Description
    Liensinine is the active constituent of plumula nelambinis with anti-hypertension.
  • In Vitro
    Liensinine Perchlorate is found to induce apoptosis and exert a significant inhibitory effect on the proliferation and colony-forming ability ofCRC cells in a dose-dependent manner without any observed cytotoxicity on normal colorectal epithelial cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Cysteine Protease
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    2385-63-9
  • Formula Weight
    711.2
  • Molecular Formula
    C37H43ClN2O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL
  • SMILES
    CN1CCc2cc(c(cc2[C@H]1Cc1ccc(cc1)O)Oc1c(ccc(c1)C[C@@H]1c2cc(c(cc2CCN1C)OC)OC)O)OC.O[Cl](=O)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhou J, et al. Autophagy. 2015;11(8):1259-79.
molnova catalog
related products
  • (Rac)-Z-Phe-Phe-FMK

    (Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .

  • Nampt-IN-1

    Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC50 of 3.1 nM.

  • MK-0674

    MK-0674 is an orally available, selective and potent cathepsin K inhibitor (IC50: 0.4 nM) that inhibits Cat B, Cat F, Cat L, and Cat S. It can be used in metabolism-related diseases.